Related Image: Intimacy and Sexuality After Cancer: Questions Answered and Concerns Addressed |
(Date:12/5/2009)CAPE TOWN, South Africa, December 5 The first Football,for Hope Centre in Khayelitsha in the outskirts of Cape Town opened its doors,today (5 December 2009). FIFA President Joseph S. Blatter was join
(Date:12/5/2009)...ggers, experts advise , , SATURDAY, Dec. 5...ple with allergies and asthma can have bad reactio...special steps to prevent sneezing and wheezing, ac... and Immunology (ACAAI). , Those who are allergic ...ificial plants, but both live and artificial trees...
(Date:12/5/2009)AVIVA today announced the launch of International Solutions, an innovative new international private medical insurance plan which follows the acclaimed modular design of its UK equivalent. In addition
(Date:12/4/2009)PALO ALTO, Calif., Dec. 4 Varian Medical Systems (NYSE: VAR ) announced today that its Board of Directors has set the regular 2010 Annual Meeting of Stockholders for February 11, 2010 with a record
(Date:12/4/2009)SAN FRANCISCO, Dec. 4 Medithrive, Inc. has won the Patient,s Choice Award as the favorite dispensary in the SF Bay Area by popular vote conducted by the online website, www.weedmaps.com. Despite on
Breaking Medicine News(10 mins):Health News:Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha 2Health News:Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha 3Health News:Keep Asthma, Allergies at Bay for the Holidays 2Health News:AVIVA's Private Health Insurance Products Solutions Go International 2Health News:Varian Medical Systems Schedules Annual Stockholder Meeting in Palo Alto 2...TA, Fla., May 21 As a health care practitioner, T... diagnosed with ovarian cancer, she knew her progn... with a clinic in Mexico offering effective new tr...Mexico for cutting edge alternative treatments. , ...
...RK, May 21 Immtech Pharmaceuticals, Inc. (OTC: IM...gin trading its common stock on the Pink OTC Marke...09 under the ticker symbol "IMMP". , , As announc...e Company,s common stock. The Corporate Complianc...
...ic Times Bring Experienced Nurses Back To Job Mark...r openings for new nurses at hospitals -- a result...sing shortage, according to Deloras Jones, RN, MS,...n in admissions is just one factor in the job mark...
...t procedure allows longer filtering, which experts...ws) -- Nighttime dialysis, done while people are a...t is probably better for their health as well, a n... actually takes longer but is done while a person ...
...ds mice lacking certain gene showed fewer signs of... News) -- A protein that might be linked to allerg...rchers, who said their finding could lead to new d...normal mice, those lacking the gene for TRPA1 had ...
...GTON, May 21 The following is a statement from ...Free Kids: , , (Logo: http://www.newscom.com/c...ign for Tobacco-Free Kids applauds U.S. Senator Pa... including the authority to crack down on tobacco ...
Other Medicine News:Health News:The Diagnosis Every Woman Dreads - Ovarian Cancer 2Health News:The Diagnosis Every Woman Dreads - Ovarian Cancer 3Health News:Immtech to be Listed on OTC Market 2Health News:Hard Times for Nursing Hires Doesn't Signal End to Shortage According to California Institute for Nursing & Health Care 2Health News:Sleeping Through Dialysis May Be the Way to Go 2Health News:Sleeping Through Dialysis May Be the Way to Go 3Health News:Sen. Patty Murray Votes to Protect America's Kids from Tobacco 2(Date:12/4/2009)ANNAPOLIS, Md., Dec. 4 PharmAthene, Inc. (NYSE Amex: PIP ), a biodefense company developing medical countermeasures against biological and chemical threats, announced today the presentation of new d
(Date:12/4/2009)ANNAPOLIS, Md., Dec. 4 PharmAthene, Inc. (NYSE Amex: PIP ), a biodefense company developing medical countermeasures against biological and chemical threats, announced today that the Company is prese
(Date:12/4/2009)MORRISTOWN, N.J., Dec. 4 Watson Pharmaceuticals, Inc. (NYSE: WPI ), a leading global specialty pharmaceutical company, today confirmed that its subsidiary, Watson Laboratories, Inc.-Florida, filed
Breaking Medicine Technology:PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 2PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 3PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 4PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 5PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 2PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 3PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 4PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 5PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 6Watson Files FDA Application for Generic Rozerem(R) 2Watson Files FDA Application for Generic Rozerem(R) 3Allen Medical Systems Announces Surgeon Spotlight Series Interview 5143 1Allen Medical Systems Announces Surgeon Spotlight Series Interview 5143 2Allen Medical Systems Announces Surgeon Spotlight Series Interview 5143 3Saint Josephs Hospital First in Georgia to Offer Noninvasive Treatment of Brain Disorders with Leksell Gamma Knife Perfexion 5141 1Saint Josephs Hospital First in Georgia to Offer Noninvasive Treatment of Brain Disorders with Leksell Gamma Knife Perfexion 5141 2Saint Josephs Hospital First in Georgia to Offer Noninvasive Treatment of Brain Disorders with Leksell Gamma Knife Perfexion 5141 3Echo Therapeutics to Present at 4th Annual JMP Securities Healthcare Conference 5139 1Echo Therapeutics to Present at 4th Annual JMP Securities Healthcare Conference 5139 2... Nastech Pharmaceutical,Company Inc. (Nasdaq: NS...al,trial evaluating the Company,s PYY3-36 Nasal Sp...ximately 500 obese patients for a six-month,random...eight loss as the,primary endpoint. The Phase 2 s...,Nastech,s PYY3-36 Nasal Spray compared to placebo...
.... 1 Sanofi-aventis,announced that the U.S. Food a...(R) (docetaxel) Injection Concentrate in combinati... therapy of locally advanced squamous cell,carcino...dergo,chemoradiotherapy and surgery. The FDA base...domized,open-label, international trial, TAX 324, ...
Other Medicine Technology:Nastech Pharmaceutical Company Announces Initiation of Phase 2 Clinical Trial for PYY3-36 Nasal Spray to Treat Obesity 2Nastech Pharmaceutical Company Announces Initiation of Phase 2 Clinical Trial for PYY3-36 Nasal Spray to Treat Obesity 3Taxotere(R) (docetaxel) Granted FDA Approval to Treat Locally Advanced Head and Neck Cancer Prior to Chemoradiotherapy and Surgery 2Taxotere(R) (docetaxel) Granted FDA Approval to Treat Locally Advanced Head and Neck Cancer Prior to Chemoradiotherapy and Surgery 3Taxotere(R) (docetaxel) Granted FDA Approval to Treat Locally Advanced Head and Neck Cancer Prior to Chemoradiotherapy and Surgery 4Woodlyn Refractor
Illuminated Phoroptor
Ultramatic RX Master PHOROPTOR Refracting Instrument - Minus Cylinder Black
Red Lens Maddox
Medicine Products: